NDC Code(s) : 0039-0067-10, 0039-0067-70, 0039-0060-13, 0039-0060-50, 0039-0060-70, 0039-0066-05, 0039-0066-50
Packager : Sanofi-Aventis U.S. LLC

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Lasixfurosemide TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0039-0067
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
furosemide(UNII: 7LXU5N7ZO5)
(furosemide - UNII:7LXU5N7ZO5) 		furosemide20 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate(UNII: EWQ57Q8I5X)
magnesium stearate(UNII: 70097M6I30)
talc(UNII: 7SEV7J4R1U)
silicon dioxide(UNII: ETJ7Z6XBU4)
Product Characteristics
Color WHITE Score no score
Shape OVAL (ellipsoidal) Size 8 mm
Flavor Imprint Code LASIX
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0039-0067-10100 in 1 BOTTLE
2NDC:0039-0067-701000 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA016273 07/01/1966
Lasixfurosemide TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0039-0060
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
furosemide(UNII: 7LXU5N7ZO5)
(furosemide - UNII:7LXU5N7ZO5) 		furosemide40 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate(UNII: EWQ57Q8I5X)
magnesium stearate(UNII: 70097M6I30)
talc(UNII: 7SEV7J4R1U)
silicon dioxide(UNII: ETJ7Z6XBU4)
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 8 mm
Flavor Imprint Code LASIX;40
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0039-0060-13100 in 1 BOTTLE
2NDC:0039-0060-50500 in 1 BOTTLE
3NDC:0039-0060-701000 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA016273 07/01/1966
Lasixfurosemide TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0039-0066
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
furosemide(UNII: 7LXU5N7ZO5)
(furosemide - UNII:7LXU5N7ZO5) 		furosemide80 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate(UNII: EWQ57Q8I5X)
magnesium stearate(UNII: 70097M6I30)
talc(UNII: 7SEV7J4R1U)
silicon dioxide(UNII: ETJ7Z6XBU4)
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 10 mm
Flavor Imprint Code LASIX;80
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0039-0066-0550 in 1 BOTTLE
2NDC:0039-0066-50500 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA016273 07/01/1966

PRINCIPAL DISPLAY PANEL

NDC 0039-0067-10
Lasix ®

furosemide

Tablets

100 Tablets

20mg

SANOFI

PRINCIPAL DISPLAY PANEL - 20 mg Bottle Label

PRINCIPAL DISPLAY PANEL

NDC 0039-0060-13
Lasix ®

furosemide

Tablets

100 Tablets

40mg

SANOFI

PRINCIPAL DISPLAY PANEL - 40 mg Bottle Label

PRINCIPAL DISPLAY PANEL

NDC 0039-0066-05
Lasix ®

furosemide

Tablets

50 Tablets

80mg

SANOFI

PRINCIPAL DISPLAY PANEL - 80 mg Bottle Label